Canaccord had all the figures in their infomercials, I mean, analyst reports. The rate of breast reconstruction was similar to Australia and the market size was 10 times or so larger with a higher ASP per device.
They screwed up by going for the big bang instead of trying to work one region first and understand all the issues before going nation wide. I wish I could sue for incompetence because that would be much easier to prove.
AXP Price at posting:
3.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)